These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9204416)

  • 1. Computational approaches to the identification of ribozyme target sites.
    James W; Cowe E
    Methods Mol Biol; 1997; 74():17-26. PubMed ID: 9204416
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA.
    Scherr M; LeBon J; Castanotto D; Cunliffe HE; Meltzer PS; Ganser A; Riggs AD; Rossi JJ
    Mol Ther; 2001 Nov; 4(5):454-60. PubMed ID: 11708882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 TAR as anchoring site for optimized catalytic RNAs.
    Puerta-Fernandez E; Barroso-del Jesus A; Romero-López C; Berzal-Herranz A
    Biol Chem; 2003 Mar; 384(3):343-50. PubMed ID: 12715885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-ribozyme targeting of human alpha-globin gene expression.
    Shen TJ; Ikonomi P; Smith R; Noguchi CT; Ho C
    Blood Cells Mol Dis; 1999; 25(5-6):361-73. PubMed ID: 10660485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-beta s-ribozyme reduces beta s mRNA levels in transgenic mice: potential application to the gene therapy of sickle cell anemia.
    Alami R; Gilman JG; Feng YQ; Marmorato A; Rochlin I; Suzuka SM; Fabry ME; Nagel RL; Bouhassira EE
    Blood Cells Mol Dis; 1999 Apr; 25(2):110-9. PubMed ID: 10389593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene silencing of HIV chemokine receptors using ribozymes and single-stranded antisense RNA.
    Qureshi A; Zheng R; Parlett T; Shi X; Balaraman P; Cheloufi S; Murphy B; Guntermann C; Eagles P
    Biochem J; 2006 Mar; 394(Pt 2):511-8. PubMed ID: 16293105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning strategies for catalytic antisense RNAs.
    Tabler M; Tsagris M
    Methods Mol Biol; 1997; 74():121-9. PubMed ID: 9204427
    [No Abstract]   [Full Text] [Related]  

  • 8. A ribozyme that enhances gene suppression in tobacco protoplasts.
    Perriman R; Graf L; Gerlach WL
    Antisense Res Dev; 1993; 3(3):253-63. PubMed ID: 8286926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligonucleotide scanning of native mRNAs in extracts predicts intracellular ribozyme efficiency: ribozyme-mediated reduction of the murine DNA methyltransferase.
    Scherr M; Reed M; Huang CF; Riggs AD; Rossi JJ
    Mol Ther; 2000 Jul; 2(1):26-38. PubMed ID: 10899825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and expression of chimeric U1/ribozyme transgenes.
    Abounader R; Montgomery R; Dietz H; Laterra J
    Methods Mol Biol; 2004; 252():209-19. PubMed ID: 15017051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity.
    Yokoyama Y; Takahashi Y; Shinohara A; Wan X; Takahashi S; Niwa K; Tamaya T
    Biochem Biophys Res Commun; 2000 Jun; 273(1):316-21. PubMed ID: 10873604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity identification of anti-caspase-3 mRNA hammerhead ribozyme in both cell-free condition and BRL-3A cells.
    Xu R; Liu J; Zhou X; Xie Q; Jin Y; Yu H; Liao D
    Chin Med J (Engl); 2001 Jun; 114(6):606-11. PubMed ID: 11780436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization in vitro and in vivo of hammerhead ribozymes directed against murine tumor necrosis factoralpha.
    MacKay SL; Tannahill CL; Auffenberg T; Ksontini R; Copeland EM; Moldawer LL
    Biochem Biophys Res Commun; 1999 Jul; 260(2):390-7. PubMed ID: 10403780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic control by a natural metabolite-responsive ribozyme.
    Micura R
    Angew Chem Int Ed Engl; 2004 Sep; 43(36):4692-4. PubMed ID: 15317007
    [No Abstract]   [Full Text] [Related]  

  • 15. Downregulation of bcl-2 expression in lymphoma cells by bcl-2 ARE-targeted modified, synthetic ribozyme.
    Luzi E; Papucci L; Schiavone N; Donnini M; Lapucci A; Tempestini A; Witort E; Nicolin A; Capaccioli S
    Cancer Gene Ther; 2003 Mar; 10(3):201-8. PubMed ID: 12637941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors altering ribozyme-mediated cleavage of tumor necrosis factor-alpha mRNA in vitro.
    Kisich KO; Freedland SJ; Erickson KL
    Biochem Biophys Res Commun; 1997 Jul; 236(1):205-11. PubMed ID: 9223453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The cleavage activity of GCV transfer vector-mediated hammerhead ribozyme for KRR1 in vitro transcript].
    Chen LF; Li JH; Zou YX; Zhao YP; Cao LL; Zhang XC
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Aug; 25(4):279-84. PubMed ID: 18038796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-specific gene delivery using RNA-targeting Tetrahymena group I intron.
    Jung HS; Kwon BS; Lee SW
    Biotechnol Lett; 2005 Apr; 27(8):567-74. PubMed ID: 15973491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant AAV-2 harboring gfp-antisense/ribozyme fusion sequences monitor transduction, gene expression, and show anti-HIV-1 efficacy.
    Hörster A; Teichmann B; Hormes R; Grimm D; Kleinschmidt J; Sczakiel G
    Gene Ther; 1999 Jul; 6(7):1231-8. PubMed ID: 10455431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of efficient ribozyme cleavage sites in target RNAs.
    Lieber A; Rohde M; Strauss M
    Methods Mol Biol; 1997; 74():45-50. PubMed ID: 9204419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.